Genomatica secures lead investor to bring equity investments to $90m

Lead investors include Casdin Capital, Viking Global Investors and Ginkgo Bioworks

Chemical manufacturing company Genomatica has secured US$90m of equity investments following a drive to increase capital.

Participants include new lead investor . . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.

Or

Subscribe now to premium content on Cosmetics Business

Companies